Vaxart Inc

NASDAQ:VXRT   3:59:58 PM EDT
8.11
-0.03 (-0.37%)
4:01:07 PM EDT: $8.11 0.00 (0.00%)
Products, Strategic Combinations

Vaxart Announces Exclusive Worldwide License Agreement With Altesa Biosciences For Its Vapendavir Antiviral Asset

Published: 07/07/2021 12:26 GMT
Vaxart Inc (VXRT) - Vaxart Announces Exclusive Worldwide License Agreement With Altesa Biosciences for Its Vapendavir Antiviral Asset.
Vaxart Inc - Milestone Payments Up to $130 Million and Royalties for Global Vapendavir Sales.
Vaxart - Altesa is Granted Worldwide, Exclusive Right to Develop, Manufacture, and Commercialize Co's Proprietary Formulation of Vapendavir.